In 2012, the first human trial of a vaccine to combat type I diabetes could be conducted, which would be tested with children and adolescents free of the disease but who presented a significant risk of developing it, as reported by Ramón Gomis, Director of the Biomedical Research Center in the Diabetes Network in Spain.
The vaccine is being developed by the Spanish scientist Pere Santamaria, and his team at the University of Calgary, in Canada.
Scientists have already identified the markers that indicate the potential risk of developing this type of diabetes, so when the vaccine has been completed, we will proceed to evaluate the people most likely to suffer type I diabetes and begin therapy with them.
In principle, it is expected that the vaccine will be administered to children who have an absolute risk of developing the disease in the next three or four years, as explained by Santamaría, who points out that although markers are already known that confirm that a child develop diabetes, not yet used because at this time you can not prevent the disease appears, so knowing that the child will get sick would only cause anguish to their parents.
In children and adolescents, diabetes occurs in ten cases per 100,000 people. The specialist said that it is a sector of the population that arouses much concern about the health problems that diabetes can cause in the future, and that is why it is a challenge to design a vaccine that prevents the onset of the disease.